FBRX

Forte Biosciences, Inc.

0.56 USD
+0.00 (+0.68%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Forte Biosciences, Inc. stock is down -6.7% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 7 June’s closed higher than May. 100% of analysts rate it a buy.

About Forte Biosciences, Inc.

Forte Biosciences is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.